BRAINCOOL AB (F:5YL) — Market Cap & Net Worth
Market Cap & Net Worth: BRAINCOOL AB (5YL)
BRAINCOOL AB (F:5YL) has a market capitalization of $21.22 Million (€18.15 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #24830 globally and #2143 in its home market, demonstrating a -10.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BRAINCOOL AB's stock price €0.06 by its total outstanding shares 394878155 (394.88 Million).
BRAINCOOL AB Market Cap History: 2021 to 2026
BRAINCOOL AB's market capitalization history from 2021 to 2026. Data shows change from $325.93 Million to $25.81 Million (-44.02% CAGR).
BRAINCOOL AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BRAINCOOL AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5YL by Market Capitalization
Companies near BRAINCOOL AB in the global market cap rankings as of May 5, 2026.
Key companies related to BRAINCOOL AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #145 globally with a market cap of $152.22 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.32 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #229 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #236 globally with a market cap of $101.71 Billion USD ( €87.00 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #145 | Abbott Laboratories | NYSE:ABT | $152.22 Billion | $87.54 |
| #211 | Stryker Corporation | NYSE:SYK | $111.32 Billion | $290.88 |
| #229 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | XETRA:2M6 | $101.71 Billion | €67.76 |
BRAINCOOL AB Historical Marketcap From 2021 to 2026
Between 2021 and today, BRAINCOOL AB's market cap moved from $325.93 Million to $ 25.81 Million, with a yearly change of -44.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €25.81 Million | +61.10% |
| 2025 | €16.02 Million | -65.58% |
| 2024 | €46.53 Million | -77.09% |
| 2023 | €203.13 Million | +227.87% |
| 2022 | €61.95 Million | -80.99% |
| 2021 | €325.93 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of BRAINCOOL AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.22 Million USD |
| MoneyControl | $21.22 Million USD |
| MarketWatch | $21.22 Million USD |
| marketcap.company | $21.22 Million USD |
| Reuters | $21.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powe… Read more